What is the prevalence of Maroteaux-Lamy Syndrome?

Maroteaux-Lamy syndrome, also known as Mucopolysaccharidosis type VI (MPS VI), is an ultra-rare lysosomal storage disorder with an estimated global prevalence ranging from 1 in 250,000 to 1 in 600,000 births. Because the condition is progressive and symptoms can be subtle in early stages, the true prevalence is likely higher than reported due to significant underdiagnosis and misdiagnosis.

What is the incidence and prevalence of Maroteaux-Lamy syndrome?

While exact figures remain elusive for many regions, studies indicate that the incidence of Maroteaux-Lamy syndrome varies significantly by population. In some cohorts, it is estimated at 1 in 250,000, while others suggest it may be as rare as 1 in 600,000. It is classified as an ultra-rare condition, meaning it affects a very small percentage of the global population. At DiseaseMaps.org, we currently support a small community of 3 individuals living with this diagnosis, highlighting the rarity and the value of connecting with others who share this specific journey.

Does Maroteaux-Lamy syndrome affect genders or ethnicities differently?

Maroteaux-Lamy syndrome is an autosomal recessive disorder, meaning it affects males and females with equal frequency. There is no known predilection for any specific ethnic group or geographic region, though founder effects can lead to higher clusters in specific populations with higher rates of consanguinity.

What are the common factors influencing diagnosis?

The clinical presentation of Maroteaux-Lamy syndrome typically begins in early childhood, though the age of onset can vary based on the severity of the mutation. Challenges in accurate data collection include:

• Variable Phenotypes: Symptoms range from rapidly progressing (severe) to slowly progressing (attenuated) forms.


• Diagnostic Delay: Because early symptoms like joint stiffness or minor skeletal changes are often attributed to other conditions, patients may wait years for a definitive diagnosis.


• Under-reporting: Many mild cases of Maroteaux-Lamy syndrome may remain undiagnosed throughout adulthood.

Next steps

• Consult with a metabolic geneticist to discuss current testing and management options for Maroteaux-Lamy syndrome.


• Connect with the Maroteaux-Lamy syndrome community at DiseaseMaps.org to share experiences with others navigating this rare diagnosis.


• Review the latest clinical trials and research updates via the National MPS Society.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• Orphanet: Rare disease database (ORPHA: 586).


• NIH Genetic and Rare Diseases Information Center (GARD): MPS VI overview.


• Online Mendelian Inheritance in Man (OMIM): Entry #253200.


• National MPS Society: Patient resources and clinical information.